文献速递免疫规划慢病防控与筛查

三种及两剂次HPV疫苗接种方案八年后年轻女性HPV16/18型感染率下降

Reduction of HPV16/18 prevalence in young women after eight years of three- and two-dose vaccination schemes.
PubMed 文献 · Vaccine · 2021-06-25

研究在免疫八年后的年轻女性中比较未接种与接种两剂或三剂HPV疫苗者高危型HPV的感染率。结果显示HPV16/18型感染率在未接种组为6.8%(95%CI 3.2-14.1%),三剂组为1.1%(95%CI 0.2-5.8%),两剂组为0.0%(95%CI 0.0-7.0%)。接种两剂双价或三剂双价/四价疫苗均与八年后HPV16/18型感染率降低相关。

要点

  • 两剂双价或三剂双价/四价HPV疫苗八年后HPV16/18感染率低于未接种者。
  • 未接种组HPV16/18感染率为6.8%,三剂组1.1%,两剂组0.0%。
  • 研究仅纳入有性行为的年轻女性,采用尿液样本检测高危型HPV DNA。

核心结论

  • 接种两剂双价或三剂双价/四价HPV疫苗与初次免疫八年后HPV16/18型感染率降低相关。

研究设计与样本

  • 对9-10岁时接种两剂双价或三剂双价/四价HPV疫苗的临床试验参与者,在八年后重新联系并纳入有性行为者,同时招募同期未接种有性行为女性作为对照。
  • 采用尿液样本检测高危型HPV DNA并比较各组感染率。

主要发现

  • HPV16/18型感染率在未接种组为6.8%(95%CI 3.2-14.1%,n=6/88)。
  • 三剂组HPV16/18型感染率为1.1%(95%CI 0.2-5.8%,n=1/93)。
  • 两剂组HPV16/18型感染率为0.0%(95%CI 0.0-7.0%,n=0/51)。

临床怎么用

  • 在评估年轻女性HPV疫苗接种效果时,可参考本研究中两剂或三剂方案八年后HPV16/18型感染率降低的观察结果。

局限性

  • 各组样本量较小,尤其两剂组仅51人,置信区间较宽。
  • 仅纳入有性行为的女性,可能影响外推性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recommendations for human papillomavirus vaccination have relied on immunogenicity studies and efficacy results derived from adult women. Insufficient information exists regarding HPV effectiveness in vaccinated girls as they become sexually active, regardless of dose scheme. We aimed to compare the prevalence of high-risk HPV between unvaccinated and vaccinated young women eight years after immunization. METHODS: After eight years, we recontacted women who received two-dose of bivalent or three-dose-either bivalent or quadrivalent-, HPV vaccine when aged 9-10 years-old as part of a clinical trial. Additionally, we recruited a contemporaneous unvaccinated woman group for comparison. Only those sexually active were included. High-risk HPV DNA was determined in urine samples and compared across groups. RESULTS: The prevalence of HPV16/18 types was 6.8% (95 %CI 3.2-14.1%) in the unvaccinated (n = 6/88), 1.1% (95 %CI 0.2-5.8%) in the three-dose (n = 1/93), and 0.0% (95 %CI 0.0-7.0%) in the two-dose group (n = 0/51). CONCLUSION: HPV vaccination, with two-dose of bivalent or three-dose schemes-either with the bivalent or quadrivalent vaccine-, was associated with a lower prevalence of HPV16/18 types eight years after primary immunization.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Carnalla M, Torres-Ibarra L, Barrientos-Gutiérrez T, et al. Reduction of HPV16/18 prevalence in young women after eight years of three- and two-dose vaccination schemes. Vaccine. 2021. PMID: 34183205. doi:10.1016/j.vaccine.2021.06.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。